[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J/OL]. CA Cancer J Clin,2018-09-12[2018-01-29].https://www.ncbi.nlm.nih.gov/pubmed/30207593.
[2] National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med,2011,365(5):395-409.
[3] Patz EF Jr, Greco E, Gatsonis C, et al.Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial[J]. Lancet Oncol,2016,17(5):590-599.
[4] 望云, 范丽, 周莹, 等. 上海地区低剂量CT筛查肺癌基线初步报告[J]. 中华健康管理学杂志,2018,12(1):51-54.
[5] Henschke CI, Yankelevitz DF, Mirtcheva R, et al.CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules[J]. Am J Roentgenol,2002,178(5):1053-1057.
[6] Scholten ET, de Jong PA, de Hoop B, et al. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules?[J]. Eur Respir J,2015,45(3):765-773.
[7] Zerhouni EA, Stitik FP, Siegelman SS, et al.CT of the pulmonary nodule: a cooperative study[J]. Radiology,1986,160(2):319-327.
[8] Wood DE, Kazerooni EA, Baum SL, et al.Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw,2018,16(4):412-441.
[9] Lindell RM, Hartman TE, Swensen SJ, et al.Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers[J]. Radiology,2007,242(2):555-562.
[10] Horeweg N, van der Aalst CM, Thunnissen E, et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial[J]. Am J Respir Crit Care Med,2013,187(8):848-854.
[11] Perandini S, Soardi G, Motton M, et al.Distribution of Solid Solitary Pulmonary Nodules within the Lungs on Computed Tomography: A Review of 208 Consecutive Lesions of Biopsy-Proven Nature[J]. Pol J Radiol,2016,81:146-151.
[12] Hostetter JM, Morrison JJ, Morris M, et al.Personalizing lung cancer risk prediction and imaging follow-up recommendations using the National Lung Screening Trial dataset[J]. J Am Med Inform Assoc,2017,24(6):1046-1051.
[13] 周清华, 范亚光, 王颖, 等. 中国肺部结节分类、诊断与治疗指南(2016年版)[J].中国肺癌杂志,2016,19(12):793-798.
[14] Larici AR, Farchione A, Franchi P, et al. Lung nodules: size still matters[J]. Eur Respir Rev,2017,26(146),pii:170025.
[15] de Hoop B, van Ginneken B, Gietema H, et al. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy[J]. Radiology,2012,265(2):611-616.
[16] Scholten ET, de Jong PA, Jacobs C, et al. Interscan varia-tion of semi-automated volumetry of subsolid pulmonary nodules[J]. Eur Radiol,2015,25(4):1040-1047.
[17] 齐琳琳, 王建卫, 杨琳, 等. 肺纯磨玻璃结节体积和质量倍增时间在鉴别浸润腺癌与微浸润腺癌及浸润前病变中的作用[J]. 中华放射学杂志,2017,51(7):493-499.
[18] Fan L, Liu SY, Li QC, et al.Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant[J]. Br J Radiol,2012,85(1015):897-904.
[19] 熊曾, 周晖, 胡成平, 等. 肺内结节CT血管集束征与强化值的关系[J]. 中华医学杂志,2013,93(38):3015-3018.
[20] Oda S, Awai K, Funama Y, et al.Detection of small pulmonary nodules on chest radiographs: efficacy of dual-energy subtraction technique using flat-panel detector chest radiography[J]. Clin Radiol,2010,65(8):609-615.
[21] Langer SG, Graner BD, Schueler BA, et al.Sensitivity of Thoracic Digital Tomosynthesis (DTS) for the Identification of Lung Nodules[J]. J Digit Imaging,2016,29(1):141-147.
[22] Gomi T, Nozaki M, Takeda T, et al.Comparison of chest dual-energy subtraction digital tomosynthesis and dual-energy subtraction radiography for detection of pulmonary nodules: initial evaluations in human clinical cases[J]. Acad Radiol,2013,20(11):1357-1363.
[23] Liang M, Tang W, Xu DM, et al.Low-Dose CT Screening for Lung Cancer: Computer-aided Detection of Missed Lung Cancers[J]. Radiology,2016,281(1):279-288.
[24] Patz EF Jr, Pinsky P, Gatsonis C, et al.Overdiagnosis in low-dose computed tomography screening for lung cancer[J]. JAMA Intern Med,2014,174(2):269-274.
[25] Ma J, Guarnera MA, Zhou W, et al.A Prediction Model Based on Biomarkers and Clinical Characteristics for Detection of Lung Cancer in Pulmonary Nodules[J]. Transl Oncol,2017,10(1):40-45.
[26] Lin Y, Leng Q, Jiang Z, et al.A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules[J]. Int J Cancer,2017,141(6):1240-1248.
[27] Liu Y, Kim J, Qu F, et al.CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma[J]. Radiology,2016, 280(1):271-280.
[28] Yi CA, Lee KS, Kim EA, et al.Solitary pulmonary nodu-les: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density[J]. Radiology,2004,233(1):191-199.
[29] Chae EJ, Song JW, Seo JB, et al.Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodu-les: initial experience[J]. Radiology,2008,249(2):671-681.
[30] 张金娥, 梁长虹, 赵振军, 等. CT肺灌注在肺结节诊断中的应用研究[J]. 中华放射学杂志,2005,39(10):1041-1045.
[31] 王素雅, 高剑波, 梁盼, 等. 一站式能谱及灌注成像鉴别诊断孤立性肺结节[J]. 实用放射学杂志,2016,32(2):200-203.
[32] Yuan X, Zhang J, Quan C, et al.Differentiation of malignant and benign pulmonary nodules with first-pass dualin-put perfusion CT[J]. Eur Radiol,2013,23(9):2469-2474.
[33] 刘芳蕾, 洪群英, 石洪成, 等. 18氟-氟代脱氧葡萄糖正电子发射计算机断层扫描在肺癌早期诊断中的应用价值[J]. 中华医学杂志,2013,93(38):3019-3022.
[34] Patz EF Jr, Lowe VJ, Hoffman JM, et al.Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning[J]. Radiology,1993,188(2):487-490.
[35] Deppen SA, Blume JD, Kensinger CD, et al.Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis[J]. JAMA,2014,312(12):1227-1236.
[36] Kagna O, Solomonov A, Keidar Z, et al.The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer[J]. Eur J Nucl Med Mol Imaging,2009,36(6):997-1004.
[37] Harders SW, Madsen HH, Hjorthaug K, et al.Characte-rization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [1?F] fluorodeoxyglucose-positron emission tomography/computed tomography[J]. Cancer Imaging,2012,12:437-446.
[38] Meier-Schroers M, Homsi R, Skowasch D, et al.Lung cancer screening with MRI: results of the first screening round[J]. J Cancer Res Clin Oncol,2018,144(1):117-125.
[39] Ohno Y, Koyama H, Yoshikawa T, et al.Standard-, Reduced-, and No-Dose Thin-Section Radiologic Examinations: Comparison of Capability for Nodule Detection and Nodule Type Assessment in Patients Suspected of Having Pulmonary Nodules[J]. Radiology,2017,284(2):562-573.
[40] 李智勇, 张婷婷, 李梦颖, 等. 磁共振动态增强曲线在孤立性肺结节诊疗中的应用研究[J]. 实用医学杂志,2012,28(22): 3790-3792.
[41] Koenigkam-Santos M, Optazaite E, Sommer G, et al.Contrast-enhanced magnetic resonance imaging of pulmonary lesions: description of a technique aiming clinical practice[J]. Eur J Radiol,2015,84(1):185-192.
[42] Shen G, Jia Z, Deng H.Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis[J]. Eur Radiol,2016,26(2):556-566.
[43] 倪广峰, 黄国鑫. 磁共振动态增强扫描及波谱成像对肺内结节性病变的鉴别诊断研究[J]. 中国CT和MRI杂志,2016,14(2):46-48,72.
[44] Sommer G, Wiese M, Winter L, et al.Preoperative sta-ging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography[J]. Eur Radiol,2012,22(12):2859-2867.
[45] Gex G, Pralong JA, Combescure C, et al.Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules: a systematic review and meta-analysis[J]. Respiration,2014,87(2):165-176.
[46] Anantham D, Koh MS, Ernst A.Endobronchial ultrasound[J]. Respir Med,2009,103(10):1406-1414.
[47] Lee SM, Park CM, Lee KH, et al.C-arm cone-beam CT-guided percutaneous transthoracic needle biopsy of lung nodules: clinical experience in 1108 patients[J]. Radiology,2014,271(1):291-300.
[48] Bhatt KM, Tandon YK, Graham R, et al.Electromagnetic Navigational Bronchoscopy versus CT-guided Percutaneous Sampling of Peripheral Indeterminate Pulmonary Nodules: A Cohort Study[J]. Radiology,2018,286(3):1052-1061.
[49] Paci M, Rapicetta C, Maramotti S.New biomarkers for lung cancer[J]. Expert Opin Med Diagn,2010,4(3):201-224.
[50] Zou J, Lv T, Zhu S, et al.Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage Ⅰ/Ⅱ lung adenocarcinoma[J]. Thorac Cancer,2017,8(3):260-270.
[51] MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017[J]. Radiology,2017,284(1):228-243.
[52] Wood DE, Kazerooni EA, Baum SL, et al.Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw,2018,16(4):412-441.
